IL10 and infection: These findings, in conjunction with indications that IL-10 is correlated significantly with gross pathology in a commercial population primary infection with E. tenella (Boulton et al., 2018), support the use of IL-10 as an accessible early-life biomarker in breeding programs aiming to enhance Eimeria resistance to challenge or pathological outcomes.